A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2006
11/30/2006	US20060269918 Compositions, splice variants and methods relating to colon specific genes and proteins
11/30/2006	US20060269917 Compositions, splice variants and methods relating to colon specific gene and proteins
11/30/2006	US20060269587 Antisense restenosis composition and method
11/30/2006	US20060269570 Recombinant double-stranded RNA phage, and use of the same
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269563 NMB1343 from Neisseria meningitidis; provides a mutant toxin having a substitution at one or more of amino Glu-109, Glu-111 or Glu-120; has reduced or eliminated ADP-ribosyltransferase and/or NAD-glycohydrolase activity
11/30/2006	US20060269559 Novel human histone deacetylases
11/30/2006	US20060269549 Tnf-alpha binding molecules
11/30/2006	US20060269548 Lymphatic endothelial cells materials and methods
11/30/2006	US20060269539 Genetic engineering; Alzheimer's agents; anticancer agents
11/30/2006	US20060269537 Glycosyl phosphatidyl inositol specific phospholipase D proteins and uses thereof
11/30/2006	US20060269532 Compositions and methods for the therapy and diagnosis of prostate cancer
11/30/2006	US20060269531 Apparatus for generating electrical pulses and methods of using the same
11/30/2006	US20060269530 RNA interference compositions and methods
11/30/2006	US20060269529 Modified t lymphocytes and uses therefor
11/30/2006	US20060269528 Production detection and use of transformant cells
11/30/2006	US20060269522 Sequence of natural or synthetic retroelements enabling nucleotide sequence insertion into a eukaryotic cell
11/30/2006	US20060269521 Avoidance of undesirable replication intermediates in plasmid propagation
11/30/2006	US20060269520 XIAP therapy
11/30/2006	US20060269519 Modulation of cytokine signaling regulators and applications for immunotherapy
11/30/2006	US20060269518 Small interference rna gene therapy
11/30/2006	US20060269484 Medicament formulations
11/30/2006	CA2610521A1 Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling
11/30/2006	CA2609937A1 Modulation of the integrin linked kinase signaling pathway to promote cardiac cell proliferation and self-renewal
11/30/2006	CA2609849A1 Chondrogenic compositions and methods of use
11/30/2006	CA2609817A1 Gene transfer method
11/30/2006	CA2609467A1 Compositions and methods for the treatment or prevention of chemoresistant neoplasia
11/30/2006	CA2609373A1 Method of producing liposomes containing gas enclosed therein
11/30/2006	CA2609276A1 Rapid production of adenovirus-free recombinant adenovirus vectors
11/30/2006	CA2606928A1 Transduction of primary cells
11/29/2006	EP1726656A2 Metalloproteinase-disintegrin family members: SVPH DNAs and polypeptides
11/29/2006	EP1726647A1 Gene promoting vascular endothelial cell growth
11/29/2006	EP1726318A1 Medicine/gene leaching type stent
11/29/2006	EP1726313A1 Drug for preventing and treating arteriosclerosis
11/29/2006	EP1726311A2 Migration of hematopoietic stem cells and progenitor cells to the liver
11/29/2006	EP1725678A1 Differential drug sensitivity
11/29/2006	EP1725660A2 Multiple promoter expression cassettes for simultaneous delivery of rnai agents
11/29/2006	EP1725657A1 Prostatic acid phosphatase antigens
11/29/2006	EP1725267A2 Enzyme-prodrug therapy for prosthetic joint repair
11/29/2006	EP1725266A2 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
11/29/2006	EP1725261A2 Use for interleukin-33 (il-33) and the il-33 receptor complex
11/29/2006	EP1725216A2 Immunoliposome-nucleic acid amplication (ilnaa) assay
11/29/2006	EP1691609A4 Delivery of viral vectors to extravascular parenchymal cells
11/29/2006	EP1497656B1 Diagnosis of carcinoma using raig1 polypeptides
11/29/2006	EP1470152A4 Peptides for increasing transfection efficiency
11/29/2006	EP1411989A4 Methods for improving cell line activity in immunoisolation devices
11/29/2006	EP1301614B1 Codon-optimized papilloma virus sequences
11/29/2006	EP1248650B1 Improved dna vaccines for bovine herpesvirus-1
11/29/2006	EP1220911B1 P-glycoproteins and uses thereof
11/29/2006	EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
11/29/2006	EP1189936B1 Use of eif4e binding agents in therapy
11/29/2006	EP1114861B1 Ly6h gene
11/29/2006	EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide
11/29/2006	EP0918848B1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/29/2006	EP0837936B1 New immunoregulatory protein lst-1
11/29/2006	CN1871355A Method for the recovery of non-segmented, nagative-stranded rna viruses from cdna
11/29/2006	CN1871034A Methods and compositions for cancer therapy using a novel adenovirus
11/29/2006	CN1871033A Trefoil factor 3 (TFF3) as a target for anti-cancer therapy
11/29/2006	CN1871030A Method of inhibiting secretase activity
11/29/2006	CN1869243A Recombined porcine adenovirus based viral vaccines and vectors
11/29/2006	CN1869242A Recombination adenovirus and its application
11/29/2006	CN1869237A Construction method of bismall molecule interference RNA carrier and its application
11/29/2006	CN1869230A Nucleotid sequence of human interleukin 21 and method and application of producing matured human interleukin 21
11/29/2006	CN1869220A Application of ShRNA pointed at HBV gene in inhibiting hepatitis B virus duplication
11/29/2006	CN1869219A Sensibility of HSD11 gene capable of increasing sensibility of tumour cell to multipile withor induction factor
11/29/2006	CN1869099A Method of preparing nanometer and micron self assembling body from poly peptide-b-polytetrahydrofuran-b-polypeptide triblock copolymer
11/29/2006	CN1869042A Antisensedigonucleotide structure with withor inhibiting factor survivin gene as target and its use
11/29/2006	CN1868545A Improved vaccines
11/29/2006	CN1868456A Prepn. of antisense deoxyoligonucleotide ISIS23665 elaioplast, and its prepn. method
11/29/2006	CN1286985C Nucleic acid relating to disease
11/29/2006	CN1286981C Combination adeno-associated virus of expression human CYP2J2 antigene and its preparation method
11/29/2006	CN1286980C Recombination adeno-associated virus of expression human antisense phospho lamban gene and its preparation method
11/29/2006	CN1286531C Antisense nucleic acids medicine composition with bcr3/abl2 and VEGF gene function inhibition and use thereof
11/29/2006	CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy
11/29/2006	CN1286524C Use of OPN for treatment and/or prevention of neurological diseases
11/28/2006	US7141662 Diagnosis using antibodies; culture product
11/28/2006	US7141658 Nucleotide sequences in the rpoB gene of spirochetes code for the beta subunit of the bacterial RNA polymerase; amplification, sequencing and comparison; complexing with genetic probes
11/28/2006	US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006	US7141651 Multiple cytokine protein complexes
11/28/2006	US7141552 Use of lipid conjugates in the treatment of diseases
11/28/2006	US7141550 Intra-tumoral administration of IL-12 encoding nucleic acid molecules
11/28/2006	US7141541 Use of peptides
11/28/2006	US7141540 Used as bioactive agent carriers for drug delivery of paclitaxel
11/28/2006	US7141425 Apparatus and method for electroporation of biological samples
11/28/2006	US7141421 Control of metabolism with human 2-oxoglutarate carrier
11/28/2006	US7141418 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments
11/28/2006	US7141408 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance
11/28/2006	US7141405 Hepatotropic flavivirus which is phylogenetic to human hepatitis C virus (GBV-B); drug screening
11/28/2006	US7141395 Biological control of crown gall disease
11/28/2006	US7141243 gM-negative EHV-mutants without heterologous elements
11/28/2006	US7141240 Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1
11/28/2006	CA2311395C Flavivirus expression and delivery system
11/28/2006	CA2282394C Retroviral vectors, methods for their preparation and their use for gene transfer into cd4-positive cells
11/28/2006	CA2076345C Transgenic animals, cells and cell lines therefrom, and their use
11/28/2006	CA2026915C Stem cell factor
11/23/2006	WO2006125165A2 Methods and compositions facilitating entry of compounds into cells
11/23/2006	WO2006125094A2 Combinatorial selection of phosphorothioate aptamers for rnases
11/23/2006	WO2006125001A2 Compositions and methods related to the intracellular effects of intracellular domains of delta1 and jagged1
11/23/2006	WO2006124904A2 Cancer treatment by combined inhibition of telomerase and hsp90 activities
11/23/2006	WO2006124686A2 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness

1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 870